Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma | PLOS ONE
Molecular Stress-inducing Compounds Increase Osteoclast Formation in a Heat Shock Factor 1 Protein-dependent Manner* - Journal of Biological Chemistry
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90 | PNAS
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration | Nature Medicine
Tanespimycin - Wikipedia
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Frontiers | Inhibition of Heat Shock Protein 90 by 17-AAG Reduces Inflammation via P2X7 Receptor/NLRP3 Inflammasome Pathway and Increases Neurogenesis After Subarachnoid Hemorrhage in Mice | Molecular Neuroscience
Pharmaceuticals | Free Full-Text | Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies | HTML
Retaspimycin - an overview | ScienceDirect Topics
Hsp90 Chaperone Inhibitor 17-AAG Attenuates Aβ-Induced Synaptic Toxicity and Memory Impairment | Journal of Neuroscience
Examples of Hsp90 N-terminal inhibitors in clinical trials. | Download Scientific Diagram
Spotlight on 17‐AAG as an Hsp90 inhibitor for molecular targeted cancer treatment - Talaei - 2019 - Chemical Biology & Drug Design - Wiley Online Library
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C | Leukemia
The germline component of 17-AAG drug susceptibility. a... | Download Scientific Diagram
The HSP90 inhibitor, 17AAG, protects the intestinal stem cell niche and inhibits graft versus host disease development | Oncogene
Frontiers | A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells | Oncology
The small-molecule kinase inhibitor D11 counteracts 17-AAG-mediated up-regulation of HSP70 in brain cancer cells | PLOS ONE
Tanespimycin (17-AAG) | HSP90 Inhibitor | MedChemExpress
Frontiers | A Novel Mechanism of 17-AAG Therapeutic Efficacy on HSP90 Inhibition in MYCN-Amplified Neuroblastoma Cells | Oncology
In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines
Altered states: selectively drugging the Hsp90 cancer chaperone: Trends in Molecular Medicine
New agents in cancer clinical trials | Oncogene
17-AAG
Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model | Anticancer Research
APExBIO - 17-AAG (KOS953)|Hsp90 inhibitor|CAS# 75747-14-7
In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines
